acoramidis improves outcomes in patients with transthyretin amyloid cardiomyopathy (attr-cm)
Published 1 year ago • 1.4K plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
0:50
the impact of acoramidis on clinical outcomes in attr-cm
-
2:43
acoramidis treatment is effective in patients with attr-cm
-
15:20
expert insights into amyloidosis: the future for patients with attr cardiac amyloidosis is brighter
-
0:56
real-world survival in patients with mixed phenotype attr-cm treated with tafamidis
-
4:40
esc 23: attribute-cm trial
-
6:06
cardiomyopathy: ttr amyloid: efficacy and safety of acoramidis in transthyretin amyloid cardiomyo...
-
2:43
3d video understanding attr amyloidosis
-
4:42
cardiac amyloidosis: evaluating patients with suspected cardiac amyloidosis
-
14:23
diagnosing attr-cm and treatment options
-
2:05
patisiran for transthyretin cardiac amyloidosis | nejm
-
16:33
transthyretin amyloid and new treatment options
-
1:40
improving the outcomes of patients with al amyloidosis and cardiac involvement
-
4:42
esc: tafamidis cuts deaths, admissions in ttr cardiac amyloidosis - medpage today
-
8:01
potential reversibility of attr-cm through anti-attr amyloid antibodies
-
16:12
transthyretin amyloid and new treatment options
-
1:07:51
hfsa 2023 cme symposium - transthyretin amyloid cardiomyopathy attr-cm
-
19:40
life with cardiac amyloidosis
-
46:47
medicine grand rounds: novel therapies in cardiac amyloidosis 9/25/18
-
5:24
wild-type transthyretin cardiac amyloidosis